Ann: Change of Director's Interest Notice, page-53

First 53 Last

Share
Profile

Follow
crazydave1942

7,204 Posts.

611

29/04/19

22:45

Post #: 38314983
Share

Originally posted by crazydave1942: ↑

Really with six to eight months to go 1 mill plus and a big whale. Nothing else matters when you have six months to achieve a target. Whale won't happen but at least show something for the years of work put in.

How can you even be happy with 100k growth for 4.3 million?

We are now at the backend of the timeframe given and gaining little momentum if this 4c is average.

Bentas what proof do you have that 250 mill is achievable?

The real question is how can Buddy keep paying for everything with no revenue?

Sheet a mobile game earns more money than Bud can make off OHM.

Bentas we all know Maccas and the rest are still customers (hang on are we sure).

So what we need from DM and the team is no more smoke and mirrors also an update on the future direction of the company. I can honestly say I'm confused, BUD changes direction like the wind without proper explanation. Now i have no idea how we pay for everything with around 10mill, they should update us on that as well.

I'm not complaining I am doing proper research and the direction and numbers don't add up. All the positive campaigners can't explain how we achieve cash flow on the OHM side and DM has said nothing.

Just remember the SP will go crashing if he announces we failed to hit the target, all IMO.

Expand

My actual prediction another average qtr spiced up by LIFX sheet, also possible hidden OHM revenue (hope not).

Last edited by crazydave1942: 29/04/19

BUD Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga